doi: 10.1016/j.peptides.2007.05.013.
Epub 2007 Jun 14.
Blockade of the nociceptin/orphanin FQ/NOP receptor system in the rat ventrolateral periaqueductal gray potentiates DAMGO analgesia
Affiliations
- PMID: 17628212
- DOI: 10.1016/j.peptides.2007.05.013
Item in Clipboard
Blockade of the nociceptin/orphanin FQ/NOP receptor system in the rat ventrolateral periaqueductal gray potentiates DAMGO analgesia
Peptides.
2007 Jul.
Abstract
Nociceptin/orphanin FQ (N/OFQ) and its receptor (NOP) are involved in various biological functions including pain. High density of NOP receptor has been found in the ventrolateral periaqueductal gray (vlPAG), the main output pathway involved in descending pain-control system. The aim of our work was to evaluate the involvement of the N/OFQ/NOP system in the modulation of MOP analgesia in the rat vlPAG using UFP-101, a selective NOP antagonist. N/OFQ significantly blocked DAMGO (a selective MOP agonist) analgesia, while UFP-101 enhanced the effect of the opioid given at a subanalgesic dose. These results confirm our hypothesis of an antiopioid role for N/OFQ in the vlPAG.
Similar articles
-
The functional antiopioid action of the ventrolateral periaqueductal gray nociceptin/orphanin FQ and nociceptin receptor system underlies DAMGO analgesic tolerance.Pharmacology. 2010;86(3):138-44. doi: 10.1159/000317070. Epub 2010 Aug 5. Pharmacology. 2010. PMID: 20689345
-
1-Benzyl-N-[3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl]pyrrolidine-2-carboxamide (Compound 24) antagonizes NOP receptor-mediated potassium channel activation in rat periaqueductal gray slices.Eur J Pharmacol. 2009 Mar 15;606(1-3):84-9. doi: 10.1016/j.ejphar.2009.01.036. Epub 2009 Feb 1. Eur J Pharmacol. 2009. PMID: 19374842
-
[Nphe1,Arg14,Lys15]N/OFQ-NH2 is a competitive antagonist of NOP receptors in the periaqueductal gray.Eur J Pharmacol. 2005 May 16;515(1-3):47-53. doi: 10.1016/j.ejphar.2005.03.036. Eur J Pharmacol. 2005. PMID: 15896734
-
Pharmacological characterization of nociceptin/orphanin FQ receptors, a novel opioid receptor family, in the midbrain periaqueductal gray.Ann N Y Acad Sci. 2004 Oct;1025:398-403. doi: 10.1196/annals.1316.049. Ann N Y Acad Sci. 2004. PMID: 15542742 Review.
-
The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.Pharmacol Ther. 2014 Mar;141(3):283-99. doi: 10.1016/j.pharmthera.2013.10.011. Epub 2013 Nov 1. Pharmacol Ther. 2014. PMID: 24189487 Free PMC article. Review.
Cited by
-
Cellular and circuit diversity determines the impact of endogenous opioids in the descending pain modulatory pathway.Front Syst Neurosci. 2022 Aug 15;16:963812. doi: 10.3389/fnsys.2022.963812. eCollection 2022. Front Syst Neurosci. 2022. PMID: 36045708 Free PMC article. Review.
-
Differential control of opioid antinociception to thermal stimuli in a knock-in mouse expressing regulator of G-protein signaling-insensitive Gαo protein.J Neurosci. 2013 Mar 6;33(10):4369-77. doi: 10.1523/JNEUROSCI.5470-12.2013. J Neurosci. 2013. PMID: 23467353 Free PMC article.
-
Bifunctional Peptide-Based Opioid Agonist-Nociceptin Antagonist Ligands for Dual Treatment of Acute and Neuropathic Pain.J Med Chem. 2016 Apr 28;59(8):3777-92. doi: 10.1021/acs.jmedchem.5b01976. Epub 2016 Apr 14. J Med Chem. 2016. PMID: 27035422 Free PMC article.
-
Current research on opioid receptor function.Curr Drug Targets. 2012 Feb;13(2):230-46. doi: 10.2174/138945012799201612. Curr Drug Targets. 2012. PMID: 22204322 Free PMC article. Review.
-
NOP-Related Mechanisms in Substance Use Disorders.Handb Exp Pharmacol. 2019;254:187-212. doi: 10.1007/164_2019_209. Handb Exp Pharmacol. 2019. PMID: 30968214 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
